Qube Research & Technologies LTD Exact Sciences Corp Transaction History
Qube Research & Technologies LTD
- $62.3 Billion
- Q2 2024
A detailed history of Qube Research & Technologies LTD transactions in Exact Sciences Corp stock. As of the latest transaction made, Qube Research & Technologies LTD holds 34 shares of EXAS stock, worth $2,408. This represents 0.0% of its overall portfolio holdings.
Number of Shares
34
Previous 8,500
99.6%
Holding current value
$2,408
Previous $587,000
99.83%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding EXAS
# of Institutions
610Shares Held
166MCall Options Held
1.93MPut Options Held
1.23M-
Vanguard Group Inc Valley Forge, PA18.2MShares$1.29 Billion0.02% of portfolio
-
Capital World Investors Los Angeles, CA16.5MShares$1.17 Billion0.12% of portfolio
-
Wellington Management Group LLP Boston, MA14.8MShares$1.05 Billion0.11% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$855 Million0.01% of portfolio
-
State Street Corp Boston, MA8.21MShares$582 Million0.02% of portfolio
About EXACT SCIENCES CORP
- Ticker EXAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 176,960,000
- Market Cap $12.5B
- Description
- Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...